Sodium lauryl sulfate as lubricant in tablets formulations: Is it worth?

Contact angle Drug release Lubrication Magnesium stearate Sodium Stearyl Fumarate Sodium dodecyl sulfate

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 19 06 2023
revised: 19 07 2023
accepted: 20 07 2023
medline: 21 8 2023
pubmed: 24 7 2023
entrez: 23 7 2023
Statut: ppublish

Résumé

Lubricants are excipients used in tablet formulations to reduce friction and adhesion forces within the die or on the punches surface during the manufacturing process. Despite these excipients are always required for the tablets production, their amount must be carefully evaluated since lubricants can negatively impact on mechanical strength, disintegration and dissolution behavior of solid dosage forms. Alternative compounds have been suggested to overcome the issues of conventional lubricants and sodium lauryl sulfate (SDS) is one of the most promising one. Despite SDS has been object of several investigations, a definitive conclusion on its effectiveness cannot still be drawn. Particularly, its efficacy on tablets disaggregation and API dissolution is still unclear. Here, the effect of SDS on all the relevant features of tablets and tableting process has been evaluated on immediate release hydrophobic tablets formulations in comparison with conventional lubricants. The results of this investigation are quite outspoken: SDS has a low lubricant power while it determines only a limited improvement on tablets hardness. It greatly improves the tablets wettability but only on model formulations, the presence of superdisintegrants resets its effectiveness and any possible effect on tablets disaggregation. None of the tested formulations showed improvement on the API dissolution rate.

Identifiants

pubmed: 37482231
pii: S0378-5173(23)00685-3
doi: 10.1016/j.ijpharm.2023.123265
pii:
doi:

Substances chimiques

Sodium Dodecyl Sulfate 368GB5141J
Lubricants 0
Excipients 0
Stearic Acids 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123265

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Beatrice Sabbatini (B)

School of Pharmacy, University of Camerino, Camerino, MC 62032, Italy.

Diego Romano Perinelli (D)

School of Pharmacy, University of Camerino, Camerino, MC 62032, Italy.

Giovanni Filippo Palmieri (G)

School of Pharmacy, University of Camerino, Camerino, MC 62032, Italy.

Marco Cespi (M)

School of Pharmacy, University of Camerino, Camerino, MC 62032, Italy. Electronic address: marco.cespi@unicam.it.

Giulia Bonacucina (G)

School of Pharmacy, University of Camerino, Camerino, MC 62032, Italy.

Articles similaires

Animals Rumen Methane Fermentation Cannabis
Flurbiprofen Tablets Administration, Oral Drug Compounding Solubility
Humans DNA, Viral Sodium Dodecyl Sulfate Hepatitis B virus Benzenesulfonates
Chloramphenicol Poloxamer Hypromellose Derivatives Gels Drug Stability

Classifications MeSH